Danimer Scientific, Inc.

Danimer Scientific, Inc.

DNMR
Danimer Scientific, Inc.US flagOther OTC
0.35
USD
- -
- -
1.06MMarket Cap
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
TTM
Revenue per Share
15.09
22.4
25.25
21.06
18.31
13.54
Basic EPS, GAAP
-9.11
-4.19
-25.83
-71.12
-60.97
-40.23
Free Cash Flow per Basic Share
-17.84
-24.64
-106.74
-89.55
-29.39
-25.99
Dividend per Share
- -
- -
- -
- -
- -
- -
Book Value per Share
-23.3
-27.81
-51.09
-118.16
-178.08
-190.24
Tangible Book Value per Share
6.78
167.62
151.68
117.38
78.52
49.14
Basic Weighted Avg Shares
2
2
2
3
3
3
Sales/Revenue/Turnover
32
47
59
53
47
37
Operating Margin (%)
-32.16
-33.25
-169.18
-232.89
-268.15
-232.12
Depreciation Expense
4
5
11
20
29
30
Net Income, GAAP
-20
-9
-60
-180
-155
-111
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-60.33
-18.7
-102.31
-337.78
-333.03
-297.1
Working Capital
-15
352
297
100
92
49
LT Debt
91
56
284
309
403
403
Total Equity
17
356
500
378
278
212
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Mar'24
Jun'24
Sep'24
ST Debt
5
11
10
LT Borrowings
384
387
382
LT Finance Leases
22
21
21
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
3
3
3
Market Capitalization
112
64
50

Working Capital

FRC

in mil. unless spec.
Mar'24
Jun'24
Sep'24
Total Current Assets
105
87
70
Cash, Cash Equivalents & STI
57
40
22
Accounts Receivable, Net
12
11
12
Inventories
26
26
26
Total Current Liabilities
16
19
21
Payables & Accruals
10
6
10
ST Debt
5
11
10
Deferred Revenue
1
1
1

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-26.37%
Free Cash Flow
- -
- -
-66.88%
Net Income, GAAP
- -
- -
-13.51%
Sales/Revenue/Turnover
- -
- -
-12.28%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
15
13
10
15
53
2023
12
13
11
11
47
2024
10
8
9
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
-10.48
-12.05
-37.5
-11.07
-71.12
2023
-14.38
-15.4
-15.74
-15.44
-60.97
2024
-10.49
-7.78
-7.3
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Company Description

MCPAPIChat
CEO
Richard N. Altice
Full Time Employees
257
Sector
Basic Materials
Industry
Chemicals - Specialty
Address
140 Industrial Boulevard Bainbridge GA United States of America 39817
IPO Date
May 28, 2020
Business
Danimer Scientific, Inc. is a leading company in performance biopolymers, dedicated to the creation and supply of biodegradable material alternatives for conventional fossil fuel-derived plastics. The firm manufactures polyhydroxyalkanoate (PHA), a renewable plastic feedstock derived from plant oils, which serves as a fully compostable and biodegradable option for various plastic uses, marketed under its Nodax™ brand. Additionally, it develops polylactic acid (PLA)-based resins suitable for coatings on items like disposable paper cups, alongside other specialized biopolymers. Its product range spans across applications such as extrusion coatings, films, injection molding, thermoforming, and additives, enabling the development of numerous articles. Danimer provides these sustainable solutions to consumer brand owners, material converters, and manufacturing entities within the plastics sector, striving to help eliminate plastic pollution. Established in 2004, Danimer Scientific, Inc. maintains its headquarters in Bainbridge, Georgia.

Company News

MCPAPIChat
  • Danimer Scientific Announces Common Stock Expected to Begin Trading Promptly on OTCQX Marketplace

  • NYSE to Commence Delisting Proceedings Against Danimer Scientific, Inc. (DNMR)

  • Danimer Scientific Takes Action to Strengthen Capital Structure

  • TerraNova Capital Equities announces three transactions totaling $45 Million

  • Danimer Scientific, Inc. (DNMR) Q3 2024 Earnings Call Transcript

  • Danimer Scientific, Inc. (DNMR) Reports Q3 Loss, Tops Revenue Estimates

  • Danimer Scientific Announces Third Quarter 2024 Results

  • Danimer Scientific Announces Release Date for Third Quarter 2024 Results

  • Danimer Scientific Announces Intention to Complete a Reverse Stock Split

  • Danimer Scientific Announces Second Circuit Court Affirms Dismissal of Class Action Lawsuit

  • Ningbo Homelink Eco-iTech and Danimer Scientific Announce Commercial Launch of Home Compostable Extrusion Coating Biopolymer Based on PHA

  • DoD Makes Award to Danimer Scientific via the Distributed Bioindustrial Manufacturing Program

  • What Makes Danimer Scientific (DNMR) a New Buy Stock

  • Danimer Scientific, Inc (DNMR) Q2 2024 Earnings Call Transcript

  • Danimer Scientific, Inc. (DNMR) Reports Q2 Loss, Lags Revenue Estimates

  • Danimer Scientific Announces Release Date for Second Quarter 2024 Results

  • Danimer Scientific Completes Dividend Distribution of Warrants to Stockholders

  • Danimer Scientific Receives Continued Listing Standard Notice from NYSE

  • Danimer Scientific Announces Steve Croskrey Retirement and Related Changes to the Company's Board of Directors

  • Danimer Scientific, Inc. (DNMR) Q1 2024 Earnings Call Transcript